Abstract. Twelve adult patients with growth hormone deficiency (GHD) were studied in regard to serum levels of immunoglobulins, immunoglobulin G (IgG) subclasses, natural killer (NK) activities, interferon (IFN) augmented NK activities and lymphokine activated killer (LAK) activities before and after one month of human growth hormone (hGH) treatment. They were compared with 114 age-matched controls. All the patients were diagnosed as having GHD in childhood and had been treated with hGH for more than 5 years. The present study was performed 1 to 7 years after the cessation of hGH treatment. Serum immunoglobulin G1 (IgG1) levels and IFN augmented NK activities in the patients were significantly lower than in the controls, although NK and LAK activities of the patients were normal. Therefore it was concluded that NK and LAK activities were maintained at normal levels without hGH in adults who had been treated with hGH, although IFN augmented NK activities were reduced without it. It seems that longer treatment with hGH is needed to produce normal levels of serum IgG1 and IFN augmented NK activities.
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All patients were given biosynthetic hGH (Somatonorm, Kabi Pharmacia AB) in a dose 0.5IU/kg/week by daily subcutaneous injections for one month. Blood samples were taken before and after the hGH trial.
The control group was composed of 50 men and 64 women aged 20 to 40 years.
Serum IgG, IgA and IgM levels were as- 
Results
Serum levels of immunoglobulins were assessed in 8 patients before the hGH trial and in 4 patients at the end of the trial. Serum levels of IgG, IgA and IgM of the patients were not significantly different from those of the controls and did not respond to hGH administration (Fig. 1) . Serum IgG subclasses were assessed in 11 patients before the hGH trial and in 5 patients at the end of the trial. Serum IgG1 levels of the patients were signifi- of the patients were significantly lower than those of controls (p <0.01) but showed no response to hGH administration.
LAK activities of the patients were lower than those of controls, but not significantly, and become normal with hGH administration (Fig.3) .
Discussion
Although hypopituitary animals show a marked deficiency of cell-mediated immune function (11), the role of GH on the development and function of the immune system in humans is not well understand.
In children with GHD, both normal (1-3) and abnormal (4-6) immune functions have been observed. Our previous report showed significantly reduced levels of NK and LAK activities stimulated by recombinant interleukin (rIL)-2 or OK432 in children with GHD, which returned to normal with hGH treatment (9). How- 
